DNA X, Inc.
SONM- Exchange
- Nasdaq
- Industry
- Telephone & Telegraph Apparatus
- SEC CIK
- 0001178697
No open-market purchases or sales by DNA X, Inc. insiders were filed in the last 90 days; 9 institutions reported holding it in 13F filings for Q2 2026, worth $453.8K in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in DNA X, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 18
- +1 vs. Q3 2023
- Shares held
- 1.40M
- +43.2K (+3.2%) vs. Q3 2023
- Total value
- $1.03M
- +$118.4K (+13.0%) vs. Q3 2023
- New holders
- 3
- 5 more added
- Sold out
- 2
- 4 more reduced
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SONM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 9 | $453.8K |
| Q1 2026 | 9 | $384.0K |
| Q4 2025 | 8 | $266.3K |
| Q3 2025 | 14 | $314.8K |
| Q2 2025 | 20 | $291.8K |
| Q1 2025 | 12 | $268.6K |
| Q4 2024 | 11 | $283.9K |
| Q3 2024 | 11 | $291.1K |
| Q2 2024 | 17 | $1.13M |
| Q1 2024 | 20 | $849.4K |
| Q4 2023 | 18 | $1.03M |
| Q3 2023 | 17 | $911.8K |
| Q2 2023 | 13 | $2.43M |
| Q1 2023 | 14 | $690.8K |
| Q4 2022 | 14 | $284.5K |
| Q3 2022 | 18 | $373.0K |
| Q2 2022 | 13 | $346.3K |
| Q1 2022 | 13 | $435.0K |
| Q4 2021 | 17 | $2.00M |
| Q3 2021 | 15 | $1.51M |
| Q2 2021 | 21 | $8.04M |
| Q1 2021 | 29 | $17.3M |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding DNA X, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 257 | $0 | 0.00% | +257 | New |
| Bank of America Corp | 24 | $18 | 0.00% | +24 | New |
| JPMorgan Chase & Co | 29 | $21 | 0.00% | +7+31.8% | Added |
| Emfo, LLC | 100 | $74 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 157 | $115 | 0.00% | +10+6.8% | Added |
| Tower Research Capital LLC (TRC) | 13,824 | $10.2K | 0.00% | +1,043+8.2% | Added |
| Citigroup Inc | 14,600 | $10.7K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 17,176 | $12.6K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 22,356 | $16.4K | 0.00% | −18,298−45.0% | Reduced |
| First Foundation Advisors | 24,616 | $18.1K | 0.00% | −23,384−48.7% | Reduced |
| Two Sigma Securities, LLC | 31,592 | $23.2K | 0.00% | +16,519+109.6% | Added |
| State Street Corp | 42,703 | $31.4K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 49,378 | $36.3K | 0.00% | −584−1.2% | Reduced |
| Renaissance Technologies LLC | 82,161 | $60.0K | 0.00% | +82,161 | New |
| Geode Capital Management, LLC | 184,213 | $135.4K | 0.00% | 00.0% | Unchanged |
| Bank of New York Mellon Corp | 206,623 | $151.8K | 0.00% | −3,542−1.7% | Reduced |
| Vanguard Group Inc | 299,736 | $220.3K | 0.00% | +3,703+1.3% | Added |
| Sicart Associates LLC | 413,000 | $303.5K | 0.12% | 00.0% | Unchanged |
| Baader Bank INC | 0 | $0 | 0.00% | −14,600−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −98−100.0% | Sold out |